Both in Pharmaceuticals
Oragenics vs Artelo Biosciences
Over the past year OGEN returned −64.2% and ARTL returned −97.4%; their daily moves had a correlation of 0.02.
OGEN −64.2% ARTL −97.4%Growth of $1, one year, split-adjusted
| Metric | OGEN | ARTL |
|---|---|---|
| Price | $0.4800 | $4.07 |
| Market cap | $2.2M | $2.2M |
| Today | +1.78% | −5.35% |
| 1 month | −8.4% | −92.4% |
| 6 months | −4.7% | −94.8% |
| Year to date | −38.7% | −87.6% |
| 1 year | −62.2% | −97.3% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $3.9M | $4.2M |
| Dividend yield | — | — |
| Volatility (60d) | 45.4% | 651.8% |
| Short % of float | 23.5% | 0.5% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).